Article
Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.
Bone marrow transplantation - 1 Aug 1991
Weisdorf D J, Haake R, Miller W J, McGlave P B, LeBien T W, Vallera D A, Lasky L C, Kim T H, Peterson B A, Ramsay N K
Abstract excerpt
From 1983 to 1989 we performed a prospective trial of 70 consecutive, in vitro purged autologous bone marrow transplants (BMT) for patients with progressive non-Hodgkin's lymphoma. Forty-nine patients had responsive disease at the time of transplantation while 21 others had refractory high risk lymphoma. Forty-two patients with B-lineage lymphoma received autologous marrow purged in vitro with monoclonal antibody...
Topics
- Adolescent
- Adult
- Bone Marrow Transplantation
- Child
- Child, Preschool
- Female
- Graft Survival
- Humans
- In Vitro Techniques
- Lymphocyte Depletion
- Lymphoma, Non-Hodgkin
